fbpx

Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians

This randomized, double-blind, placebo-controlled, cross-over study was conducted to evaluate the safety and efficacy of two-weeks of nightly sublingual cannabinoid extract (ZTL-101) in treating chronic insomnia (symptoms ≥three months).

The post Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians appeared first on Society of Cannabis Clinicians.

Leave a Reply

%d bloggers like this: